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Abstract
Wilson’s disease (WD) is a rare autosomal recessive disease due to mutations of the gene encoding the
copper-transporter ATP7B. The diagnosis is hampered by the variability of symptoms induced by copper accu-
mulation, the inconstancy of the pathognomonic signs and the absence of a reliable diagnostic test. We inves-
tigated the diagnostic potential of X-ray fluorescence (XRF) that allows quantitative analysis of multiple
elements. Studies were performed on animal models using Wistar rats (n510) and Long Evans Cinnamon
(LEC) rats (n5 11), and on human samples including normal livers (n5 10), alcohol cirrhosis (n5 8), haemo-
chromatosis (n5 10), cholestasis (n5 6) and WD (n5 22). XRF experiments were first performed using syn-
chrotron radiation to address the elemental composition at the cellular level. High-resolution mapping of
tissue sections allowed measurement of the intensity and the distribution of copper, iron and zinc while pre-
serving the morphology. Investigations were further conducted using a laboratory X-ray source for irradiating
whole pieces of tissue. The sensitivity of XRF was highlighted by the discrimination of LEC rats from wild type
even under a regimen using copper deficient food. XRF on whole formalin-fixed paraffin embedded needle
biopsies allowed profiling of the elements in a few minutes. The intensity of copper related to iron and zinc
significantly discriminated WD from other genetic or chronic liver diseases with 97.6% specificity and 100%
sensitivity. This study established a definite diagnosis of Wilson’s disease based on XRF. This rapid and versa-
tile method can be easily implemented in a clinical setting.
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Introduction
Wilson’s disease (WD), also known as hepatolenticular
degeneration, is a severe disorder of copper homeosta-
sis, caused by mutations in the gene ATP7B encoding a
copper-transporting P-type ATPase [1]. The preva-
lence of WD in Western populations was estimated to
be 1 in 30 000 [2]. However, recent genetic prevalence
studies suggested a much higher carrier frequency of
up to 1 in 7000 [3,4].
Absent or reduced function of the ATP7B protein
leads to decreased hepatocellular excretion of copper
into bile, which results in hepatic copper accumulation.
Excess copper impairs mitochondrial function, which
produces oxidative damage to cells and allows spillage
of copper into the blood, thereby overloading other
organs such as the brain, kidney, cornea and red blood
cells [5]. A further consequence of absent or reduced
ATP7B is the hepatic production and secretion of
copper-deficient ceruloplasmin, termed apoceruloplas-
min, which has a short half-life and results in
decreased blood levels of ceruloplasmin [6].
Reliable and unambiguous diagnosis of WD remains
a challenge. The direct molecular-genetic analysis of
this autosomal recessive genetic disease is cumber-
some because of the occurrence of more than 500
defective mutations reported in the ATP7B gene [7].
Furthermore, most patients are compound heterozy-
gotes carrying two different mutations each of these
being rare. This may explain the marked discrepancy
between the genetic prevalence and the number of clin-
ically diagnosed cases of WD.
The clinical presentation of WD is variable. The
accumulation of copper may induce different degrees of
acute and chronic hepatitis leading to cirrhosis, some-
times associated with haemolytic anaemia and also neu-
ropsychiatric disturbances [8]. The diagnosis is still
more difficult in patients exhibiting neuropsychiatric
disturbances without obvious liver disease. Deposition
of copper in the cornea, known as a Kayser-Fleischer
ring, is a clinical signature of WD when associated with
low levels of serum ceruloplasmin (<0.1 g/L) [8]. How-
ever, when a Kayser-Fleischer ring is not present, as is
common in the hepatic manifestation of WD [9], cerulo-
plasmin levels alone are not always reliable. Auto-
immune hepatitis, severe hepatic insufficiency in
advanced liver disease and familial aceruloplasminae-
mia may lead to false positive results [10]. On the other
hand, because ceruloplasmin also acts as an acute phase
reactant, falsely high levels may be observed in patients
with active inflammation, pregnant women or patients
taking oestrogens [11,12]. Thus in patients with liver
disease, a normal ceruloplasmin level cannot exclude
WD, nor is a low level sufficient to make a diagnosis of
WD. To overcome the limitations of serum ceruloplas-
min as a screening test for WD, several other diagnostic
tests have been proposed; namely, the estimation of 24-
hour urinary copper excretion, and more recently the
dosage of exchangeable copper. While interpretation of
the former can be difficult due to overlap with other
chronic liver diseases, such as autoimmune hepatitis
[13], the determination of serum exchangeable copper
appears to make a valuable contribution to the diagnosis
of WD [14]. However, this test has still to be evaluated
in young children or in cases of cholestasis or severe
hepatic failure [15]. Moreover sample preparation and
technical skill are required to use sophisticated equip-
ment such as an atomic absorption spectrometer [16].
Histological examination is recommended for diag-
nostic purposes when the clinical signs and noninva-
sive tests do not allow a final diagnosis or if there is
a suspicion of other or additional liver pathologies
[8]. Histological abnormalities observed in WD,
mainly macrovesicular and microvesicular steatosis,
glycogenated nuclei in hepatocytes, focal hepatocel-
lular necrosis or ‘chronic active hepatitis’ features
are not specific and can be easily misdiagnosed as
non-alcoholic fatty liver disease or autoimmune hepa-
titis. Specific copper stains such as rhodanine or indi-
rect staining of copper-associated proteins like orcein
are widely used to histochemically evaluate hepatic
copper accumulation on liver biopsy. Unfortunately,
the detection of copper in hepatocytes by routine his-
tochemical evaluation is highly variable firstly
because of the focality of copper deposition. More-
over, rhodanine and orcein can fail to reveal focal
copper stores in some patients because they detect
only lysosomal copper deposition [17]. Especially,
the early stages of the disease or the younger WD
patients, for whom the hepatocellular copper is
mainly cytosolic, are not histochemically detectable,
leading to false negative results.
X-ray fluorescence (XRF) spectroscopy is suitable
for investigating the elemental composition of biolog-
ical tissues. The principle of XRF is based on the
energy-dispersive detection of X-rays emitted during
relaxation of sample atoms excited by X-rays of
higher energy. XRF analysis is multi-elemental and
quantitative. Indeed, the detected spectrum depends
on the atomic species within the irradiated volume
and the intensity of the fluorescence is directly pro-
portional to the concentration of the elements within
the sample. Moreover, using third-generation syn-
chrotron sources, which are bright enough to generate
high flux microbeams, XRF mapping can reveal the
spatial distribution of the elements at a subcellular
level [18]. This technique has the advantages of
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being non-destructive and highly sensitive even at
trace levels without any histochemical staining or
elaborate sample preparation, which make it compati-
ble with various medical research areas [19]. XRF
analysis has allowed investigation of hepatic iron
(Fe) distribution [20], the distribution of metallopro-
teins in hepatocellular carcinoma and surrounding tis-
sues [21] as well as elemental mapping (calcium
(Ca), iron (Fe), copper (Cu), zinc (Zn) and bromine
(Br)) on liver tissue sections from patients with hae-
mochromatosis [22] or cirrhosis [23]. Interestingly,
higher accumulation of copper in a mouse animal
model of WD has been observed using synchrotron
X-ray absorption and fluorescence microspectroscopy
[24]. On the other hand, the non-invasive quantitation
of corneal copper in WD patients has been addressed
using X-ray excitation spectrometry [25]. Despite the
limited number of examined subjects, this latter study
demonstrated the high sensitivity of the XRF tech-
nique to detect copper accumulation in the cornea of
WD patients for whom Kayser-Fleischer rings were
absent [25].
Although the reported sensitivity of XRF spectros-
copy to probe the elemental composition of tissue is
high, no study of the elemental composition of the
liver from patients with WD has been reported. As
the hallmark of WD is the accumulation of copper in
the liver, we have addressed the potential of XRF for
implementing a reliable and rapid diagnosis of WD
based on the elemental composition of liver tissue.
Materials and methods
Human liver samples
Liver specimens with Wilson disease (WD) (n5 22)
(detailed information in Supplementary Table1), hae-
mochromatosis (HC) (n5 10), alcohol-induced cir-
rhosis (AC) (n5 8), primary biliary cirrhosis with
chronic cholestasis (CD) (n5 6) and normal liver
(NL) (n5 10) were obtained from the Centre de
Ressources Biologiques Paris-Sud, France (Table 1).
Access to this material was in agreement with French
ethical laws. Frozen serial sections were cut 5 lm
thick at 2208C with a CM3050-S cryostat (Leica
microsyste`mes SAS, France) and alternately depos-
ited on a glass slide for histological control, and onto
4 lm-thick polyethylene film (UltraleneVR , SPEXVR
SamplePrep, United Kingdom) for XRF microspec-
troscopy analysis.
Needle biopsy cores were fixed in alcohol-
formaldehyde-acetic acid and embedded in paraffin
wax. For XRF measurements the entire block was
used.
Sections for histology were stained with haematox-
ylin, eosin and safran (HES), or with rhodanine or
Perls staining to visualize respectively the deposition
of Cu or Fe. Fibrosis was evaluated by Picro-Sirius
staining.
Determination of copper concentration
in human liver samples
The paraffin liver samples were first deparaffinized
by toluene and then washed in ethanol. Frozen liver
samples were dried in an oven at 808C overnight and
mineralized with concentrated HNO3 in a block
digestion system (Digiprep
VR
, SCP Science, Les Ulis,
France). The samples were analyzed by Inductively
Coupled Plasma Optical Emission Spectrometry
(ICP-OES) on a 6300 DV
VR
spectrometer (Thermo
Scientific, Les Ulis, France). Calibration was made
by adding known Cu concentrations (Cu 1 g/l, Inor-
ganicTM Ventures, Christianburg, Virginia, USA) to a
bovine liver mineralisate. Certified Reference Mate-
rial (SRM Bovine Liver 1577b, NIST, Gaithersburg,
USA) was treated as for the samples. Results were
within the certified reference range (1606 8 lg/g).
Animal care and experimental procedures
Long-Evans Cinnamon (LEC) rats carrying a mutation
in the ATP7B gene (provided by the Institute for Ani-
mal Reproduction, Ibaraki, Japan), and Wistar rats
were housed at the animal facilities of Angers Univer-
sity Medical School (SCAHU) and received human
care according to the guidelines of the French Agricul-
ture Ministry. LEC rats (seven males and four females)
and Wistar rats (four males and six females) were 8
weeks old at the beginning of the study. Their food
was composed of either Altromin
VR
1320 diet normally
dosed in copper (13 ppm) or Altromin
VR
C1041 food
containing less than 1 ppm of copper (0.367 mg/kg).
Both were provided by GENESTIL
VR
(Royaucourt,
France). The LEC rats fed with Cu-deficient food as
well as all WT rats (ie fed with normal or Cu-deficient
food) were sacrificed after no longer than 18 weeks.
All LEC rats, which were fed with normally dosed
copper, developed fulminant hepatitis and were sacri-
ficed after 13–24 weeks.
Synchrotron l-XRF microspectroscopy
Synchrotron XRF microspectroscopy was carried out
at the Swiss Light Source (SLS) (Paul Scherrer
Institut, Villigen, Switzerland) at the microXAS and
cSAXS beamlines.
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Table 1. History of patients and origin of samples
N8 Gender Age (years) Histopathological diagnosis Frozen section Needle biopsy
1 M 74 Normal/CRC metastasis 1 2
2 F 30 Normal/FNH 1 2
3 F 25 Normal/FNH 1 2
4 F 54 Normal/FNH 1 2
5 F 26 Normal/FNH 1 2
6 M 39 Normal/Liposarcoma 2 1
7 F 32 Normal 2 1
8 F 44 Normal 2 1
9 M 6 Normal/portal cavernoma 2 1
10 F 41 Normal 2 1
11 M 54 Cirrhosis/Alcohol 1 2
12 M 62 Cirrhosis/Alcohol 1 2
13 M 41 Cirrhosis/Alcohol 1 2
14 M 73 Cirrhosis/Alcohol 2 1
15 M 54 Cirrhosis/Alcohol 2 1
16 M 56 Cirrhosis/Alcohol 2 1
17 F 48 Cirrhosis/Alcohol 2 1
18 M 66 Cirrhosis/Alcohol 2 1
19 M 73 Haemochromatosis/Cholangiocarcinoma 1 2
20 M 42 Haemochromatosis/HCC 1 2
21 M 47 Haemochromatosis/HCC 1 2
22 M 65 Haemochromatosis/HCC 1 2
23 M 46 Haemochromatosis 2 1
24 F 56 Haemochromatosis 2 1
25 F 57 Haemochromatosis 2 1
26 F 75 Haemochromatosis 2 1
27 M 50 Haemochromatosis 2 1
28 F 58 Haemochromatosis 2 1
29 F 76 PBC 2 1
30 M 54 PBC 2 1
31 F 53 PBC 2 1
32 F 73 PBC 2 1
33 F 55 PBC 2 1
34 M 59 PBC 2 1
35 F 15 Wilson disease 1 2
36 F 32 Wilson disease 1 2
37 M 18 Wilson disease 1 2
38 M 23 Wilson disease 1 2
39 M 20 Wilson disease 1 2
40 F 11 Wilson disease 1 2
41 F 51 Wilson disease 1 2
42 M 14 Wilson disease 1 2
43 F 10 Wilson disease 1 1
44 F 16 Wilson disease 1 1
45 M 15 Wilson disease 1 2
46 M 39 Wilson disease 1 2
47 F 24 Wilson disease 2 1
48 F 71 Wilson disease 2 1
49 M 20 Wilson disease 2 1
50 M 46 Wilson disease 2 1
51 F 25 Wilson disease 2 1
52 M 32 Wilson disease 2 1
53 F 16 Wilson disease 2 1
54 F 8 Wilson disease 2 1
55 F 13 Wilson disease 2 1
56 M 12 Wilson disease 2 1
N, Patient number; CRC, colorectal cancer; FNH, focal nodular hyperplasia; HCC, hepatocellular carcinoma; PBC, Primary biliary cirrhosis.
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The microXAS beamline operates in the energy
range 4–23 keV. A 10 keV beam was focused to about
3 3 3 lm2 (fwhm). XRF spectral maps were collected
from 2 3 2 mm2 tissue areas, at a spatial resolution of
3 lm, as determined by the size of the X-ray beam and
the step size in the raster scan mapping. The time of
acquisition was 0.2 s per pixel in the mapping. The
integrated fluorescence intensity of each element as a
function of the tissue types was plotted using the box
plots (Microcal Origin, version 6.0).
The cSAXS beamline operates in the energy range
4–19 keV and the excitation energy used in this study
was 11.2 keV. The beam was focused to about 30 3
30 lm2 (fwhm) at the sample position. The transmitted
and scattered X-ray intensity was measured with a
Pilatus 2 M pixel array (Dectris Ltd., Baden, Switzer-
land), and the fluorescence with a Si-PIN photodiode
(Amptek). The expected Ka1 fluorescence energies
[26] were 6.403, 8.048 and 8.639 keV from Fe, Cu and
Zn, respectively. An elastic scattering peak recorded at
the excitation energy of 11.2 keV was used to calibrate
the spectra. The samples were raster scanned and in
each point the full XRF spectrum was recorded with
an acquisition time of 1 s per pixel to produce XRF
maps of approximately 2 3 2 mm2 areas, at a spatial
resolution of about 30 lm. MATLAB programs
(MATLAB Release 2010b, The MathWorks, Inc.,
United States) were used to integrate the detected
intensity in the peaks corresponding to the Ka1 peaks,
in order to produce element-specific images.
Laboratory-based XRF set-up
XRF measurements were carried out on a prototype XRF
spectrometer at the Laboratoire de Physique des Solides
(Orsay, France). The sample was positioned in a X-ray
beam (8 keV) monochromatized by a doubled curved
graphite monochromator with a standard 1 mm beam
size in diameter or by a multilayer optics which delivers
a smaller beam with size of 150 lm in diameter. The flu-
orescence was detected at 908 to the X-ray beam. A
video camera was used to visualize the sample and center
it in the X-ray beam. The time of acquisition to detect
the high quality spectra was up to 30 min per localiza-
tion. Up to three different localizations were measured
for each sample. The fluorescence X-ray spectra were
peak fitted using PyMCA [27], in order to extract the
integrated intensities of Ka fluorescence lines.
Statistical analysis
The groups of patients were compared by Student t-
test using the statistical package of Microcal Origin
version 6.0. The difference between the groups was
considered to be statistically significant when
p< 0.05. Confidence interval was fixed at 95%. The
program used to perform the receiver operating char-
acteristic (ROC) analysis was XLSTAT of Microsoft
Office Excel version 12.
Results
Multi-elements mapping on tissue sections
using synchrotron XRF microspectroscopy
The elemental composition of normal and WD
human livers was addressed. Serial frozen tissue sec-
tions were performed from liver surgery specimens
(Table 1) for HES staining (Figure 1A) or XRF
microspectroscopy. Synchrotron XRF experiments
were conducted with high resolution (3 mm) to yield
the variance in elemental composition at the cellular
level. Synchrotron XRF acquisition leads to the
simultaneous detection of multi-elements such as
phosphorus (P), sulfur (S), chlorine (Cl), potassium
(K), calcium (Ca), manganese (Mn), magnesium
(Mg), iron (Fe), copper (Cu) and zinc (Zn). The
intensity of Cu related to Fe and Zn was markedly
increased in the averaged spectra obtained on WD as
compared to normal liver (Figure 1A). The elemental
distribution was further investigated on normal and
WD livers by rastering a large area of 2 3 2 mm2 on
the tissue section with a 3 lm step size. In the high-
resolution XRF maps, the distribution of all elements
appeared homogeneous on normal liver parenchyma.
In contrast, the distribution of Fe, Cu and Zn was
heterogeneous in WD samples (Figure 1B). Interest-
ingly, the accumulation of Cu in localized deposits
selectively located at the periphery of the nodule cor-
related inversely with Fe. Similarly, Zn also exhib-
ited a punctuated distribution that correlated with Cu
(Figure 1B).
Quantitative assessment of metals such as Fe, Cu
and Zn was further investigated on frozen tissue sec-
tions from 24 surgical specimens including normal
(n5 5), alcohol-induced cirrhosis (n5 3), haemoch-
romatosis (n5 4) and WD (n5 12) livers (Table 1).
For each tissue section, XRF experiments were per-
formed on a large map of 2 mm 3 2 mm with 30
lm step size leading to the acquisition of spectra in
approximately 2 h. The integrated fluorescence inten-
sities allowed us to compare the relative contribution
of each element (Figure 2A). A much higher propor-
tion of Fe was observed in patients diagnosed with
haemochromatosis whereas the proportion of Cu was
dramatically increased in all patients with WD. These
observations were of major interest considering the
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biological and clinical variability between patients
with WD (Supplementary Table 1). Indeed, genotype
analysis did not reveal any evidence for ATP7B
mutation in three patients. Moreover, 53% of patients
showed normal serum copper levels and only 42% of
patients revealed serum ceruloplasmin levels lower
than 0.1 g/l. Similarly, only 33% of hepatic cases
exhibited a detectable KF ring in the cornea. Further-
more, the histochemical staining of copper using rho-
danine was not detectable in three WD liver sections
among which two were paediatric patients, thus
yielding false negative results. In contrast, the Cu
Figure 1. SR-XRF analysis on tissue sections from normal liver and Wilson disease. (A) Tissue sections of 5 lm thickness were stained
with HES. Portal tract and centrilobular vein are present on the section of normal liver (patient #3) (upper image). WD liver (patient
#46) exhibits nodules surrounded by fibrosis (lower image). Synchrotron radiation XRF spectra were acquired on the area delimited
by the black squares. Representative XRF spectra acquired on tissue sections from normal liver and WD showing peaks characteristic
of the composite elements. (B) The distribution of Fe (green), Cu (red) and Zn (blue) in the normal liver tissue (left panel) and in the
hepatic nodule of WD tissue (right panel). The three component images are overlaid at lower right. The scale bar represents 500 lm,
where the image is 2 3 2 mm2 with 3 3 3 lm2 pixels.
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deposition was clearly identified by XRF for every
single WD patient.
The reliability of the XRF technique to diagnose
WD based on intrahepatic Cu level was further sup-
ported by marked linearity of detected Cu fluores-
cence intensity and the measured Cu hepatic tissue
concentration (Figure 2B). Finally, the fluorescence
intensity of Fe or Cu allowed us to respectively dis-
criminate patients with haemochromatosis or WD
from normal liver as well as other hepatic lesions
such as alcoholic cirrhosis (Figure 2C). These results
demonstrated the sensitive detection of metals by
XRF on frozen tissue sections allowing the diagnosis
of haemochromatosis or WD.
Profiling of Fe, Cu and Zn on fresh or fixed
tissues fragments using a laboratory-based
XRF spectrometer
The possibility of distinguishing WD from other
hepatic lesions by synchrotron radiation XRF is of
great interest for the diagnosis of this disease. How-
ever, the limited access to such a large-scale facility
prohibits extensive use of this technique as a routine
diagnostic tool for hospital purposes. We have
addressed this issue and used a laboratory-based X-
ray source (Supplementary Figure 1). Studies were
focused on the Long-Evans Cinnamon (LEC) rat that
exhibits a mutation in the ATP7B gene and thus con-
stitutes an animal model of WD [28] with inherited
disorders of copper metabolism [28–31]. XRF experi-
ments were first performed on fresh rat liver tissue
without any sample preparation. We took advantage
of the large beam size of 1 3 1 mm2 of the X-ray
source for acquiring a representative spectrum of the
elemental composition of the liver through the cross
section of the piece of tissue. Under this configura-
tion, a high quality spectrum was obtained in less
than 30 min clearly detecting the higher copper con-
tent in LEC rats as compared to wild type Wistar
rats (Figure 3A). Investigations were further focused
on the compatibility of paraffin embedded tissue for
XRF measurements. We first observed no back-
ground signal, either from formalin or paraffin. We
Figure 2. Assessment of elemental content by SR-XRF. (A) The
integrated fluorescence intensity from tissue sections shows
both the total fluorescence (bar height, y-axis) and the relative
contribution of each of the components (coloured bar section)
within 24 human liver samples; normal liver (NL), alcohol-
induced cirrhosis (AC), haemochromatosis (HC) and Wilson dis-
ease (WD) are shown alongside and empty Ultralene (U) sample
holder. (B) For each WD patient the fluorescence intensity of
the Cu was plotted as a function of intrahepatic Cu concentra-
tion measured from the same surgical specimen by atomic
emission spectrometry (r25 0.95). (C) The X-ray fluorescence
intensities of Fe and Cu within the different liver pathologies:
NL (n5 5), AC (n5 3), HC (n5 4) and WD (n5 12).
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compared the latter XRF spectrum obtained on
unfixed liver of LEC rats with a measurement on the
same sample fixed in formalin and subsequently
embedded in paraffin (FFPE). The spectra obtained
on unfixed tissue (fresh or snap frozen) and FFPE
were identical, demonstrating the versatility of XRF
with regards to the sample preparation (Figure 3A).
The ability of XRF spectroscopy to detect multiple
elements such as Fe, Cu and Zn was leveraged in the
perspective of WD diagnosis. Indeed, copper content
was estimated as the calculation of a ratio of Cu flu-
orescence intensity to the integrated fluorescence
intensity from all three metals. The major advantage
of this ratio is that it is independent of the acquisition
conditions; it accounts for variations in the thickness
of the tissue, as well as the incident irradiance and
the detection geometry. The estimated copper content
by XRF on FFPE liver tissue from LEC rats (n5 5)
and Wistar rats (n5 5) significantly discriminated the
LEC rats from wild types (Figure 3B). Finally, the
ability of the XRF to discriminate LEC rats from
WT rats whatever their copper intake regimen was
addressed. XRF measurements were performed on
the FFPE tissue from LEC rats (n5 6) and Wistar
rats (n5 5) under feeding with Cu-deficient food (<1
ppm). The results highlighted the sensitivity of XRF,
allowing us to discriminate the LEC rats from WT,
despite a very low Cu intake regimen (Figure 3B).
Altogether, these observations strengthened the versa-
tility and sensitivity of XRF spectroscopy using a
laboratory-based instrument for the discrimination of
WD.
Discriminating WD on FFPE human liver needle
biopsies by XRF spectroscopy
The study was focused on the estimation of copper
content on FFPE human liver needle biopsies that
constitute a common biological material for the diag-
nostic of WD [13]. Experiments were performed
using our laboratory-based XRF spectrometer with a
focalized X-ray beam of 150 lm diameter size. Spec-
tra were acquired for 30 min on FFPE needle biop-
sies from normal and WD livers. Under these
conditions, we observed interpretable spectra exhibit-
ing good signal to noise ratios thus allowing the mea-
surement of intensities of Fe, Cu and Zn (Figure 4A).
The study was further extended to FFPE needle biop-
sies from normal liver (n5 5), alcohol-induced cir-
rhosis (AC) (n5 5), primary biliary cirrhosis as a
model of chronic cholestasis (CD) (n5 6), haemo-
chromatosis (HC) (n5 6) and adult WD (n5 6)
(Table 1). The Cu content was estimated using the
ratio of Cu fluorescence intensity to the integrated
fluorescence intensity from Fe, Cu and Zn as
described above. No significant differences were
noticed between normal liver, AC, CD and HC
(p> 0.5) although a moderate increase of Cu content
was visible in AC and CD liver specimens (Figure
4B). In contrast, the copper content measured by
XRF allows discriminating with high significance all
Figure 3. XRF analysis on whole pieces of unfixed or fixed tis-
sues from animal models. (A) Representative XRF spectra
obtained on whole pieces of unfixed tissues from wild type
(WT) rat and LEC rat (model of WD), or obtained on tissue
embedded in paraffin (FFPE). The time of spectrum acquisition
was 30 min. (B) Relative Cu content expressed as ratio of Cu/
(Cu1 Fe1 Zn) measured by XRF in the liver of WT and LEC rat
which were fed with normal (13 ppm) or low (1 ppm) content
of copper. LEC rats (n5 5) and WT rats (n5 5) received normal
food (eg food with 13 mg/L; 13 ppm Cu content); LEC rats
(n5 6) and WT rats (n5 5) received food with low Cu content
(eg 1 mg/L; 1 ppm). A statistically significant difference was
found between the LEC and the WT groups for both intake
regimen (p< 0.05).
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of the WD patients from patients with other liver dis-
eases (Figure 4B).
Investigations on the WD patients were further
based on patient’s age: WD adult (age >16 years)
(n5 6) and paediatric WD patients (age 16 years)
(n5 6). Interestingly, a significantly higher copper
level was detected using XRF on FFPE needle biop-
sies within the paediatric WD patients as compared
to the adult WD patients. This observation was con-
firmed in a retrospective analysis of 11 frozen WD
liver tissue sections (Table 1) previously probed by
synchrotron XRF microscopy (Supplementary Figure
2A). Indeed, the intrahepatic Cu concentrations (Sup-
plementary Figure 2B) and the XRF intensity levels
of Cu (Supplementary Figure 2C) both confirmed
this tendency. These results strengthen the interest of
XRF for diagnosis of paediatric WD patients.
ROC analysis was investigated to determine sensi-
tivity, specificity and predictive value of fluorescence
intensity of Cu for WD diagnosis. The ROC curve
analysis (Figure 4C) was performed on XRF data
from FFPE liver biopsies of WD patients (adult and
paediatric) and all other groups (including normal
liver). This suggested that the most useful cutoff
value for WD diagnosis based on the ratio of Cu flu-
orescence intensity to the integrated fluorescence
intensity from Fe, Cu and Zn was 0.134. This cutoff
offered a 100% sensitivity and 97.6% specificity.
The high sensitivity and specificity allow the definite
diagnosis of every single patient with WD. Indeed,
any mis-diagnosed WD patient exhibiting false nega-
tive features such as negative rhodanine staining after
histochemical examination can be now diagnosed
without ambiguity by XRF fluorescence (Figure 5).
Altogether these results demonstrated the high
potential of XRF spectroscopy as an efficient method
to provide the reliable diagnosis of WD.
Discussion
This study focused on the diagnosis of Wilson’s dis-
ease, which is still challenging due to the variety of
Figure 4. Diagnosis of WD by XRF on FFPE needle biopsy. (A)
Comparison of XRF spectra measured from formalin-fixed paraf-
fin-embedded (FFPE) needle biopsy from normal liver and from
a patient with WD. The time of spectra acquisition was 30 min.
(B) Cu content expressed as ratio of Cu/(Cu1 Fe1 Zn) meas-
ured by XRF within FFPE needle biopsy from normal liver (NL)
(n5 5), alcohol-induced cirrhosis (AC) (n5 5), cholestasis (CD)
(n5 6), hemochromatosis (HC) (n5 6) and Wilson disease adult
(age >16 years) (WD Adult) (n5 6) and paediatric Wilson
disease patients (WD Paediatric) (age 16 years) (n5 6); **
p< 0.05. (C) Receiver operating characteristic (ROC) curve for
XRF as a diagnostic test for WD on paraffin liver biopsies (red
dashed line). The Cu fluorescence intensity from the FFPE needle
biopsies from normal liver, alcohol-induced cirrhosis, chronic
cholestasis, haemochromatosis and Wilson disease were used to
perform the ROC analysis. Area under the curve (AUC) with
95% confidence interval is AUC5 0.999. Gray line indicates the
threshold of significance.
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mutations invalidating the ATP7B gene, the variability
of clinical symptoms and the limitations of histological
examination in the assessment of the disease. The
development of alternative diagnostic methods is all
the more important since failure of diagnosis has been
identified as the principal cause of death [7], as the
undiagnosed patients do not benefit from the existing
therapeutic options in WD (eg D-penicillamine, Trie-
thylenetetramine dihydrochloride or Zn salts).
We have implemented a XRF spectroscopy-based
approach on liver tissue as a diagnostic tool that exhib-
its major advantages. Indeed, XRF is a non-destructive
method that allows simultaneous quantitative analysis
of multiple elements. The reliability of XRF technique
to evaluate the intrahepatic Cu level was further sup-
ported by the fair correlation between the detected Cu
fluorescence intensity and the measured hepatic tissue
Cu concentration, which represents a diagnostic gold
standard for WD. The versatility of XRF is underlined
by the possibility to perform experiments on unfixed
(fresh or frozen) or fixed tissues such as FFPE sam-
ples. XRF experiments can be performed on tissue sec-
tions that allow investigating the multi-elemental
composition and distribution at the cellular level using
synchrotron radiation while conserving the morphol-
ogy. On the other hand, the global elemental composi-
tion can be obtained by irradiating a whole piece of
tissue using a laboratory-based XRF spectrometer.
Using any of these configurations, one can establish a
rapid diagnosis based on metals content since high-
resolution mapping of a tissue section using synchro-
tron radiation is performed in 2 h whereas a representa-
tive spectrum on FFPE biopsy is acquired in less than
30 min. We have demonstrated that the estimation of
Cu content related to Fe and Zn by the calculation of a
ratio independent of the experimental conditions leads
to the statistically significant discrimination of WD
from other liver diseases such as alcoholic-induced
Figure 5. Comparison of copper detection by histochemical rhodanine staining and by XRF on two patients with Wilson disease. For
each patient tissue sections of 5 lm thickness were stained with rhodanine (left) (scale bar: 1 mm) and XRF spectra were acquired
(right) in 30 min. (A) Patient #55 represents positivity in Cu detection by histochemical rhodanine staining as well as by XRF. (B)
Patient #53 shows false negativity for Cu deposits by rhodanine staining whereas XRF allowed the detection of high Cu intensity in
the tissue.
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cirrhosis, chronic cholestasis or haemochromatosis.
The sensitivity of XRF is highlighted by the discrimi-
nation of LEC rats from wild types even under regimen
with copper deficient food, and by the diagnosis of all
patients with WD despite important discrepancies in
their serum copper, ceruloplasmin levels and absence
of Kayser-Fleischer ring. From the biochemical tests
only 24-hour urinary copper excretion was in support
of the WD diagnosis (positivity for 94% presented
patients cases). More importantly, XRF allowed us to
diagnose WD patients, whatever the disease presenta-
tion (hepatic or neurological), the age or the underly-
ing treatment. The XRF not only confirmed the higher
hepatic copper level in young patients as already
reported [32] but also allowed us to diagnose WD in
patients with negative rhodanine staining on liver tis-
sue sections. Finally, our study demonstrates the high
accuracy and reliability of XRF yielding 100% sensi-
tivity and 97.6% specificity in identifying WD.
In conclusion, this study positions XRF as a versatile
and powerful method for the diagnosis of WD on liver
tissue. The high compatibility of XRF with clinical
samples such as tissue sections or FFPE needle biop-
sies as well as the possibility to perform analysis on
laboratory-based devices will allow simply implement-
ing this fast and inexpensive diagnostic method at the
hospital. We anticipate that XRF will open new ave-
nues in the diagnosis and follow-up of patients with
diseases related to metals homeostasis such as WD.
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SUPPLEMENTARY MATERIAL ON THE INTERNET
The following supplementary material may be found in the online version of this article:
Supplementary Table 1. History of patients with Wilson disease.
Supplementary Figure 1. The laboratory-based set-up for XRF measurements.
Supplementary Figure 2. Copper content in adult and paediatric patients with Wilson disease. (A) Cu content measured by SR-XRF within
human Wilson disease liver sections (n5 11) and by atomic emission spectrometry. The Cu content is presented for patients of different age:
Wilson disease adult (age >16 years) (Adult WD) (n5 5) and paediatric Wilson disease (Paediatric WD) patients (age 16 years) (n5 6). (B)
Cu content measured by atomic emission spectrometry in adult WD (n5 5) and in paediatric WD patients (n5 6). (C) X-ray fluorescence
intensities of Cu within the different liver pathologies: normal liver tissue (NL) (n5 5); alcohol-induced cirrhosis (AC) (n5 3); haemochroma-
tosis (HC) (n5 4) and Wilson disease adult (WD Adult) (n5 5) and paediatric Wilson disease patients (WD Paediatric) (age 16 years)
(n5 6). Two stars indicate a statistically significant difference between the groups (p< 0.05).
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